
DOI . ORG {
}
Title[redir]:
Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy | Medical Oncology
Description:
microRNA-133a (miR-133a) and miR-133b, located on chromosome 18 in the same bicistronic unit, have been commonly identified as being downregulated in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the correlation of miR-133a/b expression with efficacy of paclitaxel-based chemotherapy and clinical outcome of ESCC patients. miR-133a expression and miR-133b expression were examined in 100 newly diagnosed ESCC patients prior to treatment by quantitative real-time PCR. Then, the patients received four cycles of paclitaxel-based chemotherapy, the short-term treatment efficacy was evaluated, and a 3-year follow-up was performed. Expression levels of miR-133a and miR-133b were both significantly lower in ESCC tissues compared to adjacent noncancerous tissues (both P < 0.001). In addition, combined miR-133a/b downregulation was found to be closely correlated with advanced tumor stage (P = 0.02) and poor differentiation (P = 0.01). Moreover, the response rate of ESCC patients to paclitaxel-based chemotherapy was significantly higher in combined miR-133a/b downregulation group compared with other groups (P = 0.02). Furthermore, univariate and multivariate Cox analyses revealed that tumor stage and combined expression of miR-133a/b were independent prognosis factors in ESCC patients. Our data offer the convincing evidence that combined expression of miR-133a and miR-133b may predict chemosensitivity of patients with ESCC undergoing paclitaxel-based chemotherapy, implying its importance in applying āpersonalized cancer medicineā in the clinical treatment of ESCC. We also identified combined expression of miR-133a and miR-133b as an effective prognostic marker of this malignancy.
Matching Content Categories {š}
- Education
- Telecommunications
- Health & Fitness
Content Management System {š}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {š}
What is the average monthly size of doi.org audience?
šļø Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 80,479,999 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {šø}
We can't see how the site brings in money.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.
Keywords {š}
pubmed, article, google, scholar, cell, cancer, carcinoma, esophageal, squamous, central, cas, wang, expression, patients, chen, mirb, zhou, escc, mira, microrna, zhang, micrornaa, paclitaxelbased, chemotherapy, combined, access, oncol, treatment, tumor, privacy, cookies, content, chemosensitivity, jin, invasion, seki, yang, lin, data, information, publish, research, search, downregulation, micrornab, peng, zhu, mirab, prognosis, prognostic,
Topics {āļø}
quantitative real-time pcr microrna-10b-3p targets foxo3 month download article/chapter xilei zhouĀ &Ā wanwei wang microrna-133b predicts chemosensitivity paclitaxel-based chemotherapy related subjects short-term treatment efficacy paclitaxel-based chemoradiation cancer cell proliferation lianāshui county people full article pdf mir-133a tumor suppressor cell biochem biophys nanjing medical university privacy choices/manage cookies tumour suppressor mir-133b drug combination chemotherapy independent prognosis factors cell death dis colorectal cancer cells cervical carcinoma development negatively regulates tbpl1 recurrent prostate cancer human cancers downregulation group compared gastric cancer cells regulating myoblast proliferation microrna-206/133b clusters mir-133a target bmc cancer advanced tumor stage european economic area adjacent noncancerous tissues check access expert opin pharmacother oral maxillofac res curr drug targets erk1/2 pathway involving downstream effector proteins purine nucleoside phosphorylase improved local control instant access esophageal cancer colorectal cancer patients combined mir-133a/ altered mirna expression conditions privacy policy embo mol med pharmgenomics pers med
Questions {ā}
- Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
Schema {šŗļø}
WebPage:
mainEntity:
headline:Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy
description:microRNA-133a (miR-133a) and miR-133b, located on chromosome 18 in the same bicistronic unit, have been commonly identified as being downregulated in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the correlation of miR-133a/b expression with efficacy of paclitaxel-based chemotherapy and clinical outcome of ESCC patients. miR-133a expression and miR-133b expression were examined in 100 newly diagnosed ESCC patients prior to treatment by quantitative real-time PCR. Then, the patients received four cycles of paclitaxel-based chemotherapy, the short-term treatment efficacy was evaluated, and a 3-year follow-up was performed. Expression levels of miR-133a and miR-133b were both significantly lower in ESCC tissues compared to adjacent noncancerous tissues (both PĀ <Ā 0.001). In addition, combined miR-133a/b downregulation was found to be closely correlated with advanced tumor stage (PĀ =Ā 0.02) and poor differentiation (PĀ =Ā 0.01). Moreover, the response rate of ESCC patients to paclitaxel-based chemotherapy was significantly higher in combined miR-133a/b downregulation group compared with other groups (PĀ =Ā 0.02). Furthermore, univariate and multivariate Cox analyses revealed that tumor stage and combined expression of miR-133a/b were independent prognosis factors in ESCC patients. Our data offer the convincing evidence that combined expression of miR-133a and miR-133b may predict chemosensitivity of patients with ESCC undergoing paclitaxel-based chemotherapy, implying its importance in applying āpersonalized cancer medicineā in the clinical treatment of ESCC. We also identified combined expression of miR-133a and miR-133b as an effective prognostic marker of this malignancy.
datePublished:2014-10-04T00:00:00Z
dateModified:2014-10-04T00:00:00Z
pageStart:1
pageEnd:8
sameAs:https://doi.org/10.1007/s12032-014-0263-6
keywords:
microRNA-133
Esophageal squamous cell carcinoma
Chemosensitivity
Prognosis
Quantitative real-time PCR
Oncology
Hematology
Pathology
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-014-0263-6/MediaObjects/12032_2014_263_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-014-0263-6/MediaObjects/12032_2014_263_Fig2_HTML.gif
isPartOf:
name:Medical Oncology
issn:
1559-131X
1357-0560
volumeNumber:31
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Guiming Chen
affiliation:
name:Lianāshui County Peopleās Hospital
address:
name:Department of Thoracic Surgery, Lianāshui County Peopleās Hospital, Lianāshui, China
type:PostalAddress
type:Organization
type:Person
name:Jin Peng
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Weiguo Zhu
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Guangzhou Tao
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Yaqi Song
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Xilei Zhou
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Wanwei Wang
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy
description:microRNA-133a (miR-133a) and miR-133b, located on chromosome 18 in the same bicistronic unit, have been commonly identified as being downregulated in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the correlation of miR-133a/b expression with efficacy of paclitaxel-based chemotherapy and clinical outcome of ESCC patients. miR-133a expression and miR-133b expression were examined in 100 newly diagnosed ESCC patients prior to treatment by quantitative real-time PCR. Then, the patients received four cycles of paclitaxel-based chemotherapy, the short-term treatment efficacy was evaluated, and a 3-year follow-up was performed. Expression levels of miR-133a and miR-133b were both significantly lower in ESCC tissues compared to adjacent noncancerous tissues (both PĀ <Ā 0.001). In addition, combined miR-133a/b downregulation was found to be closely correlated with advanced tumor stage (PĀ =Ā 0.02) and poor differentiation (PĀ =Ā 0.01). Moreover, the response rate of ESCC patients to paclitaxel-based chemotherapy was significantly higher in combined miR-133a/b downregulation group compared with other groups (PĀ =Ā 0.02). Furthermore, univariate and multivariate Cox analyses revealed that tumor stage and combined expression of miR-133a/b were independent prognosis factors in ESCC patients. Our data offer the convincing evidence that combined expression of miR-133a and miR-133b may predict chemosensitivity of patients with ESCC undergoing paclitaxel-based chemotherapy, implying its importance in applying āpersonalized cancer medicineā in the clinical treatment of ESCC. We also identified combined expression of miR-133a and miR-133b as an effective prognostic marker of this malignancy.
datePublished:2014-10-04T00:00:00Z
dateModified:2014-10-04T00:00:00Z
pageStart:1
pageEnd:8
sameAs:https://doi.org/10.1007/s12032-014-0263-6
keywords:
microRNA-133
Esophageal squamous cell carcinoma
Chemosensitivity
Prognosis
Quantitative real-time PCR
Oncology
Hematology
Pathology
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-014-0263-6/MediaObjects/12032_2014_263_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-014-0263-6/MediaObjects/12032_2014_263_Fig2_HTML.gif
isPartOf:
name:Medical Oncology
issn:
1559-131X
1357-0560
volumeNumber:31
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Guiming Chen
affiliation:
name:Lianāshui County Peopleās Hospital
address:
name:Department of Thoracic Surgery, Lianāshui County Peopleās Hospital, Lianāshui, China
type:PostalAddress
type:Organization
type:Person
name:Jin Peng
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Weiguo Zhu
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Guangzhou Tao
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Yaqi Song
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Xilei Zhou
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
type:Person
name:Wanwei Wang
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Medical Oncology
issn:
1559-131X
1357-0560
volumeNumber:31
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Lianāshui County Peopleās Hospital
address:
name:Department of Thoracic Surgery, Lianāshui County Peopleās Hospital, Lianāshui, China
type:PostalAddress
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Guiming Chen
affiliation:
name:Lianāshui County Peopleās Hospital
address:
name:Department of Thoracic Surgery, Lianāshui County Peopleās Hospital, Lianāshui, China
type:PostalAddress
type:Organization
name:Jin Peng
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
name:Weiguo Zhu
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
name:Guangzhou Tao
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
name:Yaqi Song
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
name:Xilei Zhou
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
name:Wanwei Wang
affiliation:
name:Nanjing Medical University
address:
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Thoracic Surgery, Lianāshui County Peopleās Hospital, Lianāshui, China
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
name:Department of Radiotherapy, Huaiāan First Peopleās Hospital, Nanjing Medical University, Huaiāan, China
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {š}(192)
- What's the financial gain of https://link.springer.com/privacystatement?
- Find out how much https://link.springer.com/article/10.1007/s12032-014-0263-6/#main earns monthly
- Check the income stats for https://link.springer.com
- Income figures for https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s12032-014-0263-6
- How much money does https://link.springer.com/article/10.1007/s12032-014-0263-6/#eds-c-header-nav make?
- How much does https://link.springer.com/journals/ make?
- How much does https://www.springernature.com/gp/authors make?
- How much income is https://link.springernature.com/home/ earning monthly?
- How much income does https://link.springer.com/article/10.1007/s12032-014-0263-6/#eds-c-header-popup-search have?
- What are the earnings of https://order.springer.com/public/cart?
- What's https://link.springer.com/article/10.1007/s12032-014-0263-6/'s gross income?
- What's the financial intake of https://link.springer.com/article/10.1007/s12032-014-0263-6/journal/12032?
- Learn about the earnings of https://link.springer.com/article/10.1007/s12032-014-0263-6/#citeas
- What is the monthly revenue of https://link.springer.com/article/10.1007/s12032-014-0263-6/journal/12032/aims-and-scope?
- What's the monthly money flow for https://submission.springernature.com/new-submission/12032/3?
- What's the profit of https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Guiming-Chen-Aff1?
- How much does https://link.springer.com/article/10.1007/s12032-014-0263-6/#Aff1 gross monthly?
- How much does https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Jin-Peng-Aff2 bring in each month?
- How much does https://link.springer.com/article/10.1007/s12032-014-0263-6/#Aff2 bring in each month?
- How much does https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Weiguo-Zhu-Aff2 pull in?
- Learn how profitable https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Guangzhou-Tao-Aff2 is on a monthly basis
- How much income does https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Yaqi-Song-Aff2 have?
- Learn about the earnings of https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Xilei-Zhou-Aff2
- https://link.springer.com/article/10.1007/s12032-014-0263-6/#auth-Wanwei-Wang-Aff2's financial summary
- How much revenue does https://link.springer.com/article/10.1007/s12032-014-0263-6/article/10.1007/s12032-014-0263-6/metrics bring in?
- What's the monthly money flow for https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs12032-014-0263-6?
- What's the revenue for https://link.springer.com/product/springer-plus?
- How much money does https://www.springernature.com/gp/librarians/licensing/agc/journals make?
- What's the financial outcome of https://link.springer.com/10.1186/s13046-018-0966-1?fromPaywallRec=true?
- How much revenue does https://link.springer.com/10.1038/onc.2017.29?fromPaywallRec=true bring in?
- How much does https://link.springer.com/10.1186/s12957-016-0985-3?fromPaywallRec=true generate monthly?
- Get to know https://link.springer.com/article/10.1007/s12032-014-0263-6/subjects/cancer-epigenetics's earnings
- What's the monthly income of https://link.springer.com/article/10.1007/s12032-014-0263-6/subjects/cancers?
- What's the monthly money flow for https://link.springer.com/article/10.1007/s12032-014-0263-6/subjects/cancer-therapeutic-resistance?
- Profit of https://link.springer.com/article/10.1007/s12032-014-0263-6/subjects/mirnas
- How much revenue does https://link.springer.com/article/10.1007/s12032-014-0263-6/subjects/oncology generate?
- Revenue of https://link.springer.com/article/10.1007/s12032-014-0263-6/subjects/small-cell-lung-cancer
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25133032 generate?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133529 rake in every month?
- Profit of http://scholar.google.com/scholar_lookup?&title=Current%20status%20of%20predictive%20biomarkers%20for%20neoadjuvant%20therapy%20in%20esophageal%20cancer&journal=World%20J%20Gastrointest%20Pathophysiol.&volume=5&pages=322-334&publication_year=2014&author=Uemura%2CN&author=Kondo%2CT
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24868443 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032955 pull in monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Current%20management%20of%20esophageal%20cancer&journal=J%20Thorac%20Dis.&volume=6&issue=Suppl%202&pages=S253-S264&publication_year=2014&author=D%E2%80%99Journo%2CXB&author=Thomas%2CPA?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23675862?
- Check the income stats for https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3sXpt1CjsLw%3D
- http://scholar.google.com/scholar_lookup?&title=Treatment%20options%20for%20esophageal%20squamous%20cell%20carcinoma&journal=Expert%20Opin%20Pharmacother&doi=10.1517%2F14656566.2013.801454&volume=14&pages=1345-1354&publication_year=2013&author=Nakajima%2CM&author=Kato%2CH income
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24834142 earn?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021328?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20treatment%20for%20esophageal%20squamous%20cell%20carcinoma&journal=World%20J%20Gastrointest%20Oncol.&doi=10.4251%2Fwjgo.v6.i5.121&volume=6&pages=121-128&publication_year=2014&author=Baba%2CY&author=Watanabe%2CM&author=Yoshida%2CN&author=Baba%2CH?
- https://link.springer.com/doi/10.1186/1477-7819-10-173's total income per month
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22920951 makes per month
- Explore the financials of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3sXjtlensA%3D%3D
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495900 pull in?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20versus%20adjuvant%20treatment%3A%20which%20one%20is%20better%20for%20resectable%20esophageal%20squamous%20cell%20carcinoma%3F&journal=World%20J%20Surg%20Oncol.&doi=10.1186%2F1477-7819-10-173&volume=10&publication_year=2012&author=Xu%2CY&author=Yu%2CX&author=Chen%2CQ&author=Mao%2CW earns monthly
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15264049?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Molecular%20aspects%20of%20esophageal%20squamous%20cell%20carcinoma%20carcinogenesis&journal=Arq%20Gastroenterol&doi=10.1590%2FS0004-28032003000400011&volume=40&pages=256-261&publication_year=2003&author=Lehrbach%2CDM&author=Nita%2CME&author=Cecconello%2CI?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24935956 make?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119351 have monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=Development%20of%20microRNA%20therapeutics%20is%20coming%20of%20age&journal=EMBO%20Mol%20Med.&doi=10.15252%2Femmm.201100899&volume=6&pages=851-864&publication_year=2014&author=Rooij%2CE&author=Kauppinen%2CS
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25114582 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126202 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=MicroRNA%20binding%20site%20polymorphisms%20as%20biomarkers%20in%20cancer%20management%20and%20research&journal=Pharmgenomics%20Pers%20Med.&volume=7&pages=173-191&publication_year=2014&author=Cipollini%2CM&author=Landi%2CS&author=Gemignani%2CF generate monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=MicroRNA%20and%20diseases%3A%20therapeutic%20potential%20as%20new%20generation%20of%20drugs&journal=Biochimie&doi=10.1016%2Fj.biochi.2014.05.004&volume=104C&pages=12-26&publication_year=2014&author=Wahid%2CF&author=Khan%2CT&author=Kim%2CYY make?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24422025 generate?
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886106 is on a monthly basis
- How much revenue does http://scholar.google.com/scholar_lookup?&title=MicroRNA%20deregulations%20in%20head%20and%20neck%20squamous%20cell%20carcinomas&journal=J%20Oral%20Maxillofac%20Res.&volume=4&publication_year=2013&author=Chen%2CD&author=Cabay%2CRJ&author=Jin%2CY&author=Wang%2CA&author=Lu%2CY&author=Shah-Khan%2CM&author=Zhou%2CX produce monthly?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24769072
- How much revenue does https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC2cXnslGnt7c%3D produce monthly?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=MiRNA%20expression%20profile%20reveals%20a%20prognostic%20signature%20for%20esophageal%20squamous%20cell%20carcinoma&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2014.04.013&volume=350&pages=34-42&publication_year=2014&author=Chen%2CZ&author=Li%2CJ&author=Tian%2CL&author=Zhou%2CC&author=Gao%2CY&author=Zhou%2CF&author=Shi%2CS&author=Feng%2CX&author=Sun%2CN&author=Yao%2CR&author=Shao%2CK&author=Li%2CN&author=Qiu%2CB&author=Tan%2CF&author=He%2CJ?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24975488 generate monthly?
- How much profit does https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC2cXhsVGisrjN generate?
- How much does http://scholar.google.com/scholar_lookup?&title=microRNA-133%3A%20expression%2C%20function%20and%20therapeutic%20potential%20in%20muscle%20diseases%20and%20cancer&journal=Curr%20Drug%20Targets&doi=10.2174%2F1389450115666140627104151&volume=15&pages=817-828&publication_year=2014&author=Yu%2CH&author=Lu%2CY&author=Li%2CZ&author=Wang%2CQ net monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24287695 have monthly?
- https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3sXhvVyktLvE's financial summary
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847338?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20feedback%20circuit%20between%20miR-133%20and%20the%20ERK1%2F2%20pathway%20involving%20an%20exquisite%20mechanism%20for%20regulating%20myoblast%20proliferation%20and%20differentiation&journal=Cell%20Death%20Dis&doi=10.1038%2Fcddis.2013.462&volume=4&publication_year=2013&author=Feng%2CY&author=Niu%2CLL&author=Wei%2CW&author=Zhang%2CWY&author=Li%2CXY&author=Cao%2CJH&author=Zhao%2CSH generate monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23206218
- Check the income stats for https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3sXhs1Slsr3I
- How much does http://scholar.google.com/scholar_lookup?&title=MicroRNA-133%20inhibits%20cell%20proliferation%2C%20migration%20and%20invasion%20by%20targeting%20epidermal%20growth%20factor%20receptor%20and%20its%20downstream%20effector%20proteins%20in%20bladder%20cancer&journal=Scand%20J%20Urol.&doi=10.3109%2F00365599.2012.748821&volume=47&pages=423-432&publication_year=2013&author=Zhou%2CY&author=Wu%2CD&author=Tao%2CJ&author=Qu%2CP&author=Zhou%2CZ&author=Hou%2CJ generate monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22308266 generate?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292888?
- How profitable is http://scholar.google.com/scholar_lookup?&title=microRNA-1%2F133a%20and%20microRNA-206%2F133b%20clusters%3A%20dysregulation%20and%20functional%20roles%20in%20human%20cancers&journal=Oncotarget.&volume=3&pages=9-21&publication_year=2012&author=Nohata%2CN&author=Hanazawa%2CT&author=Enokida%2CH&author=Seki%2CN?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25170220?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145774 generate?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Decreased%20expression%20of%20miR-133a%20correlates%20with%20poor%20prognosis%20in%20colorectal%20cancer%20patients&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.v20.i32.11340&volume=20&pages=11340-11346&publication_year=2014&author=Wang%2CLL&author=Du%2CLT&author=Li%2CJ&author=Liu%2CYM&author=Qu%2CAL&author=Yang%2CYM&author=Zhang%2CX&author=Zheng%2CGX&author=Wang%2CCX
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24944666
- What's the profit of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC2cXpt1SltbY%3D?
- What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961467?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Role%20of%20microRNA-133a%20in%20epithelial%20ovarian%20cancer%20pathogenesis%20and%20progression&journal=Oncol%20Lett.&volume=7&pages=1043-1048&publication_year=2014&author=Luo%2CJ&author=Zhou%2CJ&author=Cheng%2CQ&author=Zhou%2CC&author=Ding%2CZ?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24816813?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016005?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=MicroRNA-133a%20suppresses%20multiple%20oncogenic%20membrane%20receptors%20and%20cell%20invasion%20in%20non-small%20cell%20lung%20carcinoma&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0096765&volume=9&publication_year=2014&author=Wang%2CLK&author=Hsiao%2CTH&author=Hong%2CTM&author=Chen%2CHY&author=Kao%2CSH&author=Wang%2CWL&author=Yu%2CSL&author=Lin%2CCW&author=Yang%2CPC each month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24870791's total income per month
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=MiR-133b%20acts%20as%20a%20tumor%20suppressor%20and%20negatively%20regulates%20TBPL1%20in%20colorectal%20cancer%20cells&journal=Asian%20Pac%20J%20Cancer%20Prev&doi=10.7314%2FAPJCP.2014.15.8.3767&volume=15&pages=3767-3772&publication_year=2014&author=Xiang%2CKM&author=Li%2CXR?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24967583 generate monthly?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072786?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=miR-1%20and%20miR-133b%20are%20differentially%20expressed%20in%20patients%20with%20recurrent%20prostate%20cancer&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0098675&volume=9&publication_year=2014&author=Karatas%2COF&author=Guzel%2CE&author=Suer%2CI&author=Ekici%2CID&author=Caskurlu%2CT&author=Creighton%2CCJ&author=Ittmann%2CM&author=Ozen%2CM?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24391788 earning monthly?
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877051
- http://scholar.google.com/scholar_lookup?&title=MiR-133b%20is%20down-regulated%20in%20human%20osteosarcoma%20and%20inhibits%20osteosarcoma%20cells%20proliferation%2C%20migration%20and%20invasion%2C%20and%20promotes%20apoptosis&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0083571&volume=8&publication_year=2013&author=Zhao%2CH&author=Li%2CM&author=Li%2CL&author=Yang%2CX&author=Lan%2CG&author=Zhang%2CY's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22179829 pull in?
- What is the earnings of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3MXhs1elurrJ?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=MicroRNA-133b%20is%20a%20key%20promoter%20of%20cervical%20carcinoma%20development%20through%20the%20activation%20of%20the%20ERK%20and%20AKT1%20pathways&journal=Oncogene&doi=10.1038%2Fonc.2011.561&volume=31&pages=4067-4075&publication_year=2012&author=Qin%2CW&author=Dong%2CP&author=Ma%2CC&author=Mitchelson%2CK&author=Deng%2CT&author=Zhang%2CL&author=Sun%2CY&author=Feng%2CX&author=Ding%2CY&author=Lu%2CX&author=He%2CJ&author=Wen%2CH&author=Cheng%2CJ
- What's the monthly income of https://link.springer.com/doi/10.1186/1471-2407-14-34?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24443799's gross income?
- How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925791 have?
- How much does http://scholar.google.com/scholar_lookup?&title=MiR-133b%20is%20frequently%20decreased%20in%20gastric%20cancer%20and%20its%20overexpression%20reduces%20the%20metastatic%20potential%20of%20gastric%20cancer%20cells&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-14-34&volume=14&publication_year=2014&author=Zhao%2CY&author=Huang%2CJ&author=Zhang%2CL&author=Qu%2CY&author=Li%2CJ&author=Yu%2CB&author=Yan%2CM&author=Yu%2CY&author=Liu%2CB&author=Zhu%2CZ earn?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20943850
- What's the financial outcome of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsF2js7zI?
- What's http://scholar.google.com/scholar_lookup?&title=Expression%20profile%20of%20microRNAs%20in%20serum%3A%20a%20fingerprint%20for%20esophageal%20squamous%20cell%20carcinoma&journal=Clin%20Chem&doi=10.1373%2Fclinchem.2010.147553&volume=56&pages=1871-1879&publication_year=2010&author=Zhang%2CC&author=Wang%2CC&author=Chen%2CX&author=Yang%2CC&author=Li%2CK&author=Wang%2CJ&author=Dai%2CJ&author=Hu%2CZ&author=Zhou%2CX&author=Chen%2CL&author=Zhang%2CY&author=Li%2CY&author=Qiu%2CH&author=Xing%2CJ&author=Liang%2CZ&author=Ren%2CB&author=Yang%2CC&author=Zen%2CK&author=Zhang%2CCY's gross income?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22641236's gross income?
- What are the earnings of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC38Xht1ajt7%2FO?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=CD47%20expression%20regulated%20by%20the%20miR-133a%20tumor%20suppressor%20is%20a%20novel%20prognostic%20marker%20in%20esophageal%20squamous%20cell%20carcinoma&journal=Oncol%20Rep&volume=28&pages=465-472&publication_year=2012&author=Suzuki%2CS&author=Yokobori%2CT&author=Tanaka%2CN&author=Sakai%2CM&author=Sano%2CA&author=Inose%2CT&author=Sohda%2CM&author=Nakajima%2CM&author=Miyazaki%2CT&author=Kato%2CH&author=Kuwano%2CH?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21351259 pull in?
- https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtlWhs7fI income
- How much money does http://scholar.google.com/scholar_lookup?&title=miR-145%2C%20miR-133a%20and%20miR-133b%3A%20tumor-suppressive%20miRNAs%20target%20FSCN1%20in%20esophageal%20squamous%20cell%20carcinoma&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.25284&volume=127&pages=2804-2814&publication_year=2010&author=Kano%2CM&author=Seki%2CN&author=Kikkawa%2CN&author=Fujimura%2CL&author=Hoshino%2CI&author=Akutsu%2CY&author=Chiyomaru%2CT&author=Enokida%2CH&author=Nakagawa%2CM&author=Matsubara%2CH make?
- How much profit is https://link.springer.com/doi/10.1007/s12013-013-9554-3 making per month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23516093 make?
- https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3sXhs12qsbfE's financial summary
- How much profit is http://scholar.google.com/scholar_lookup?&title=Altered%20miRNA%20expression%20is%20associated%20with%20differentiation%2C%20invasion%2C%20and%20metastasis%20of%20esophageal%20squamous%20cell%20carcinoma%20%28ESCC%29%20in%20patients%20from%20Huaian%2C%20China&journal=Cell%20Biochem%20Biophys&doi=10.1007%2Fs12013-013-9554-3&volume=67&pages=657-668&publication_year=2013&author=Fu%2CHL&author=Wu%2CP&author=Wang%2CXF&author=Wang%2CJG&author=Jiao%2CF&author=Song%2CLL&author=Xie%2CH&author=Wen%2CXY&author=Shan%2CHS&author=Du%2CYX&author=Zhao%2CYP making per month?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22068816
- Check the income stats for https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC38XhtVGgsrs%3D
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261671
- How much does http://scholar.google.com/scholar_lookup?&title=Tumour%20suppressors%20miR-1%20and%20miR-133a%20target%20the%20oncogenic%20function%20of%20purine%20nucleoside%20phosphorylase%20%28PNP%29%20in%20prostate%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2011.462&volume=106&pages=405-413&publication_year=2012&author=Kojima%2CS&author=Chiyomaru%2CT&author=Kawakami%2CK&author=Yoshino%2CH&author=Enokida%2CH&author=Nohata%2CN&author=Fuse%2CM&author=Ichikawa%2CT&author=Naya%2CY&author=Nakagawa%2CM&author=Seki%2CN pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22089643 bring in each month?
- What's the financial intake of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC38XhsVKrtrc%3D?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Tumor%20suppressive%20microRNA-133a%20regulates%20novel%20molecular%20networks%20in%20lung%20squamous%20cell%20carcinoma&journal=J%20Hum%20Genet&doi=10.1038%2Fjhg.2011.126&volume=57&pages=38-45&publication_year=2012&author=Moriya%2CY&author=Nohata%2CN&author=Kinoshita%2CT&author=Mutallip%2CM&author=Okamoto%2CT&author=Yoshida%2CS&author=Suzuki%2CM&author=Yoshino%2CI&author=Seki%2CN?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22266319
- How much profit does https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC38Xhs1Giu78%3D generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20suppressive%20microRNA-133a%20regulates%20novel%20targets%3A%20moesin%20contributes%20to%20cancer%20cell%20proliferation%20and%20invasion%20in%20head%20and%20neck%20squamous%20cell%20carcinoma&journal=Biochem%20Biophys%20Res%20Commun.&doi=10.1016%2Fj.bbrc.2012.01.030&volume=418&pages=378-383&publication_year=2012&author=Kinoshita%2CT&author=Nohata%2CN&author=Fuse%2CM&author=Hanazawa%2CT&author=Kikkawa%2CN&author=Fujimura%2CL&author=Watanabe-Takano%2CH&author=Yamada%2CY&author=Yoshino%2CH&author=Enokida%2CH&author=Nakagawa%2CM&author=Okamoto%2CY&author=Seki%2CN bring in each month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18449912's revenue stream
- How profitable is http://scholar.google.com/scholar_lookup?&title=Improved%20local%20control%20by%20surgery%20and%20paclitaxel-based%20chemoradiation%20for%20esophageal%20squamous%20cell%20carcinoma%3A%20results%20of%20a%20retrospective%20non-randomized%20study&journal=J%20Surg%20Oncol&doi=10.1002%2Fjso.21063&volume=98&pages=34-41&publication_year=2008&author=Hsu%2CFM&author=Lin%2CCC&author=Lee%2CJM&author=Chang%2CYL&author=Hsu%2CCH&author=Tsai%2CYC&author=Lee%2CYC&author=Cheng%2CJC?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24023359 have?
- Financial intake of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC3sXhsF2ltbbI
- How much income does http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20of%20metastatic%20or%20recurrent%20esophageal%20squamous%20cell%20carcinoma%20in%20patients%20receiving%20three-drug%20combination%20chemotherapy&journal=Anticancer%20Res&volume=33&pages=4123-4128&publication_year=2013&author=Chen%2CWW&author=Lin%2CCC&author=Huang%2CTC&author=Cheng%2CAL&author=Yeh%2CKH&author=Hsu%2CCH have?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23205070?
- What's the income of https://link.springer.com/article/10.1007/s12032-014-0263-6/articles/cas-redirect/1:CAS:528:DC%2BC38XhsVyjsrrO?
- How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506672 have?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Cyclin%20A%20overexpression%20is%20associated%20with%20chemosensitivity%20to%20paclitaxel-based%20chemotherapy%20in%20patients%20with%20esophageal%20squamous%20cell%20carcinoma&journal=Oncol%20Lett.&volume=4&pages=607-611&publication_year=2012&author=Huang%2CJX&author=Shen%2CSL&author=Lin%2CM&author=Xiao%2CW&author=Chen%2CWC&author=Lin%2CMS&author=Yu%2CH&author=Chen%2CP&author=Qian%2CRY make?
- What's the profit of https://citation-needed.springer.com/v2/references/10.1007/s12032-014-0263-6?format=refman&flavour=references?
- How much profit does https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Guiming%20Chen make?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guiming%20Chen have?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guiming%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- How profitable is https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Jin%20Peng?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jin%20Peng?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jin%20Peng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Earnings of https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Weiguo%20Zhu
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Weiguo%20Zhu bring in each month?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Weiguo%20Zhu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income of https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Guangzhou%20Tao?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guangzhou%20Tao income
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guangzhou%20Tao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income of https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Yaqi%20Song?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yaqi%20Song
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yaqi%20Song%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Xilei%20Zhou make?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xilei%20Zhou?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xilei%20Zhou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- https://link.springer.com/article/10.1007/s12032-014-0263-6/search?sortBy=newestFirst&dc.creator=Wanwei%20Wang's total income per month
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wanwei%20Wang generate?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wanwei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- Find out how much https://link.springer.com/article/10.1007/s12032-014-0263-6/mailto:[email protected] earns monthly
- Discover the revenue of https://s100.copyright.com/AppDispatchServlet?title=Combined%20downregulation%20of%20microRNA-133a%20and%20microRNA-133b%20predicts%20chemosensitivity%20of%20patients%20with%20esophageal%20squamous%20cell%20carcinoma%20undergoing%20paclitaxel-based%20chemotherapy&author=Guiming%20Chen%20et%20al&contentID=10.1007%2Fs12032-014-0263-6©right=Springer%20Science%2BBusiness%20Media%20New%20York&publication=1357-0560&publicationDate=2014-10-04&publisherName=SpringerNature&orderBeanReset=true
- Discover the revenue of https://crossmark.crossref.org/dialog/?doi=10.1007/s12032-014-0263-6
- Monthly income for https://citation-needed.springer.com/v2/references/10.1007/s12032-014-0263-6?format=refman&flavour=citation
- What's the revenue for https://link.springer.com/article/10.1007/s12032-014-0263-6/search?query=microRNA-133&facet-discipline="Medicine%20%26%20Public%20Health"?
- What's the financial gain of https://link.springer.com/article/10.1007/s12032-014-0263-6/search?query=Esophageal%20squamous%20cell%20carcinoma&facet-discipline="Medicine%20%26%20Public%20Health"?
- https://link.springer.com/article/10.1007/s12032-014-0263-6/search?query=Chemosensitivity&facet-discipline="Medicine%20%26%20Public%20Health"'s total income per month
- How much does https://link.springer.com/article/10.1007/s12032-014-0263-6/search?query=Prognosis&facet-discipline="Medicine%20%26%20Public%20Health" generate monthly?
- Get to know https://link.springer.com/article/10.1007/s12032-014-0263-6/search?query=Quantitative%20real-time%20PCR&facet-discipline="Medicine%20%26%20Public%20Health"'s earnings
- How much does https://link.springer.com/journals/a/1 pull in?
- Earnings of https://link.springer.com/books/a/1
- Check the income stats for https://link.springer.com/journals
- How much cash flow does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral have monthly?
- What's https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's gross income?
- What's the financial outcome of https://www.springernature.com/gp/products?
- How profitable is https://www.springernature.com/gp/librarians?
- How much does https://www.springernature.com/gp/societies pull in?
- Profit of https://www.springernature.com/gp/partners
- Check the income stats for https://www.springer.com/
- How much does https://www.nature.com/ pull in monthly?
- https://www.biomedcentral.com/ income
- What are the total earnings of https://www.palgrave.com/?
- Learn about the earnings of https://www.apress.com/
- What's the profit of https://link.springer.com/brands/discover?
- How much profit does https://www.springernature.com/gp/legal/ccpa generate?
- How much does https://www.springernature.com/gp/info/accessibility earn?
- Learn how profitable https://link.springer.com/termsandconditions is on a monthly basis
- How much does https://support.springernature.com/en/support/home net monthly?
- How much money does https://link.springer.com/legal-notice generate?
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations pull in monthly?
- Monthly income for https://www.springernature.com/
Analytics and Tracking {š}
- Google Tag Manager
Libraries {š}
- Clipboard.js
- Prism.js
Emails and Hosting {āļø}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {š¦}
- Crossref